Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Detection of Survivin and COX-2 in Thyroid Carcinoma: Anaplastic Carcinoma Shows Overexpression of Nuclear Survivin and Low COX-2 Expression

´ëÇѺ´¸®ÇÐȸÁö 2012³â 46±Ç 1È£ p.55 ~ 60
±è¿ë¾Æ, Àå¹Ì¼ö, ¹Ú¿µÁÖ, ±èÁöÀº,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¿ë¾Æ ( Kim Young-A ) 
Seoul National University College of Medicine Department of Pathology

Àå¹Ì¼ö ( Chang Mee-Soo ) 
Seoul National University College of Medicine Department of Pathology
¹Ú¿µÁÖ ( Park Young-Joo ) 
Seoul National University College of Medicine Department of Internal Medicine
±èÁöÀº ( Kim Ji-Eun ) 
Seoul National University College of Medicine Department of Pathology

Abstract


Background: Overexpression of survivin, a member of the inhibitors of apoptosis protein, has been reported in various carcinomas, and its interaction with cyclooxygenase 2 (COX-2) results in accelerated tumor progression. The purpose of this study is to investigate the immunohistochemical expression of survivin and COX-2 in benign and malignant thyroid tissues and to define its association with pathologic and clinical features.

Methods: We examined expression of survivin and COX-2 by immunohistochemistry in 334 benign and malignant thyroid tissues and evaluated their clinical significance.

Results: Expression of survivin showed an increase along the spectrum of thyroid carcinoma progression; rarely positive in adenomatous goiter, moderately positive in papillary carcinoma, and strongly positive in anaplastic carcinoma (AC). Papillary microcarcinoma revealed the highest COX-2 positivity and AC demonstrated the lowest positivity among thyroid cancers. Node negative carcinomas showed higher COX-2 expression than node positive tumors. Survivin expression did not correlate with COX-2.

Conclusions: Our findings suggest that survivin overexpression may be related to the pathogenesis of AC and can be a predictor of disease progression. COX-2 may be involved in the early phase of thyroid carcinoma.

Å°¿öµå

Thyroid gland; BIRC5 protein; human; Cyclooxygenase 2; Thyroid cancer; anaplastic

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS